Overview
Dr. Aaron B. Waxman is the director of the Pulmonary Vascular Disease Program at Brigham and Women’s Hospital (BWH). He is also an associate professor of medicine at Harvard Medical School.After receiving his medical degree from Yale University School of Medicine, Dr. Waxman completed a residency in internal medicine at Yale New Haven Hospital. He then completed two fellowships: the first at Howard Hughes Medical Institute, and the second in pulmonary and critical care at Yale New Haven Hospital. He is board certified in critical care medicine, internal medicine and pulmonary disease.Dr. Waxman’s clinical interests include pulmonary arterial hypertension (PAH), right heart failure, thromboembolic disease and pulmonary vascular disease. His research focuses on the inflammatory mechanisms of pulmonary vascular remodeling that lead to right heart failure. His research into the regulation of cell death proteins by IL-6 cytokines in mice led to the discovery of a relationship between dyspnea and mitochondrial dysfunction, and resulted in additional clinical studies examining the abnormalities of inflammatory mediators and oxygen extraction in patients with PAH. He has authored over 110 peer-reviewed publications and has received funding from the National Institutes of Health and the National Heart, Lung, and Blood Institute.
Dr. Waxman is rated as an Advanced provider by MediFind in the treatment of Emphysema. His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Interstitial Lung Disease, Lung Transplant, and Thrombectomy.
His clinical research consists of co-authoring 152 peer reviewed articles and participating in 19 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 4 clinical trials in the study of Emphysema.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
70 Francis Street, Carl J. And Ruth Shapiro Cardiovascular Center, Boston, MA 02115
15 Francis Street, 2nd Floor, Boston, MA 02115
2000 Washington Street, Newton, MA 02462
Additional Areas of Focus
Dr. Waxman has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
16 Clinical Trials
Dr. Edwin Kepner Silverman is chief of the Channing Division of Network Medicine and a physician at Brigham and Women’s Hospital (BWH). He is also a professor of medicine at Harvard Medical School.He received his medical degree from Washington University School of Medicine. He then completed a residency in internal medicine and a fellowship in pulmonary disease at BWH. He is board certified in critical care medicine and pulmonary medicine.Dr. Silverman’s clinical interests include alpha 1-antitrypsin deficiency, emphysema, pulmonary fibrosis and chronic obstructive pulmonary disease (COPD). He has served as a principal investigator of multiple COPD genetics studies funded by the National Institutes of Health, including the NETT Genetics Ancillary Study, the Transcontinental COPD Genetics Study, the Alpha-1 Antitrypsin Genetic Modifiers Study and the COPDGene Study. His research uses a variety of genetic analysis approaches to investigate the genetic influences of complex lung diseases, including integrative genomics, linkage analysis, familial aggregation analysis, rare variant analysis and epigenetic studies. He has authored over 320 peer-reviewed publications and is the recipient of the BWH Kenneth L. Baughman Faculty Mentoring Award. Dr. Silverman is rated as an Elite provider by MediFind in the treatment of Emphysema. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Bronchitis, and Pulmonary Fibrosis.
Brigham And Women's Hospital, Lung Center
Dr. George R. Washko, Jr. is a physician at Brigham and Women’s Hospital (BWH). He is also an associate professor of medicine at Harvard Medical School.He received his medical degree from Georgetown University School of Medicine. He then completed a residency in internal medicine at Beth Israel Deaconess Medical Center, followed by a fellowship in pulmonary disease at BWH. He is board certified in critical care medicine and pulmonary disease.Dr. Washko is a National Institutes of Health-funded investigator in chronic obstructive pulmonary disease (COPD), specifically focusing his work in imaging and quantitative image analysis. As the regional principal investigator on the National Heart, Lung, and Blood Institute’s COPD clinical research network, he is researching therapies for the prevention and treatment of COPD. He has written over 140 peer-reviewed publications, is the recipient of the Parker B. Francis fellowship and is a member of the American Society of Clinical Investigation. Dr. Washko is rated as a Distinguished provider by MediFind in the treatment of Emphysema. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Acute Interstitial Pneumonia, and Interstitial Lung Disease.
South Shore Hospital
Samuel Ash is an Intensive Care Medicine provider in South Weymouth, Massachusetts. Dr. Ash has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Emphysema. His top areas of expertise are Emphysema, Chronic Obstructive Pulmonary Disease (COPD), Acute Interstitial Pneumonia, and Interstitial Lung Disease.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Pulmonary HypertensionDr. Waxman isElite. Learn about Pulmonary Hypertension.
- Distinguished
- Acute Interstitial PneumoniaDr. Waxman isDistinguished. Learn about Acute Interstitial Pneumonia.
- Interstitial Lung DiseaseDr. Waxman isDistinguished. Learn about Interstitial Lung Disease.
- Pulmonary Veno-Occlusive DiseaseDr. Waxman isDistinguished. Learn about Pulmonary Veno-Occlusive Disease.
- Advanced
- Cerebral HypoxiaDr. Waxman isAdvanced. Learn about Cerebral Hypoxia.
- EmphysemaDr. Waxman isAdvanced. Learn about Emphysema.
- Heart Failure with Preserved Ejection Fraction (HFpEF)
- Experienced
- Bronchiolitis ObliteransDr. Waxman isExperienced. Learn about Bronchiolitis Obliterans.
- BullaeDr. Waxman isExperienced. Learn about Bullae.
- Chronic Obstructive Pulmonary Disease (COPD)
- Hypersensitivity PneumonitisDr. Waxman isExperienced. Learn about Hypersensitivity Pneumonitis.
- HyperventilationDr. Waxman isExperienced. Learn about Hyperventilation.
- Idiopathic Pulmonary FibrosisDr. Waxman isExperienced. Learn about Idiopathic Pulmonary Fibrosis.